IGF1R and ovarian serous carcinoma: IGF-1 and its receptor insulin-like growth factor 1 receptor (IGF-1R) are overexpressed in serous ovarian carcinoma [8]; the activation of this signaling pathway enhances the proliferation and tumorigenicity in OC cell lines [9] and is shown to be associated with chemoresistance [10,11].